30 news items
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
LLY
24 May 24
in the Lebanon site, located within Indiana’s LEAP Research and Innovation District, Lilly expects to add 200 full-time jobs for highly
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
LLY
24 May 24
at the LEAP Research and Innovation District in Lebanon. The new $5.3 billion expansion brings Lilly's total LEAP investment to $9 billion
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
LLY
24 May 24
Indiana's LEAP Research and Innovation District, Lilly expects to add 200 full-time jobs
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
LLY
23 May 24
. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible
Lexaria Awards Contract To A CRO To Perform The Co's Human Pilot Study #3, Which Will Evaluate A Dual Action GLP-1 + GIP
LEXX
LLY
23 May 24
. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator
tr8imtudyxxwfid7aq8r3q8g1xjj268igovn4yiogmsah
LLY
NVO
21 May 24
obesity drug, mazdutide, with its Chinese partner Innovent Biologics Inc., while several companies are developing biosimilar
c72ljz4 h1s164jzmhou0jyo47g1afnz5wl8jil2rkppbw
LLY
21 May 24
is committed to developing innovative treatments, like mirikizumab, that may improve upon the standard of care for people impacted by inflammatory bowel
bpyfszug3cof7r5q0pt2ge6uyvcmu0nank1k35brzdvx8xmsca88rgov
ABBV
JNJ
LLY
21 May 24
to a recent press release, the company's presentation will focus on its innovative cancer therapies, including the progress of its lead candidate
m0elkg mab4eznv02jrdvvzlk21pz
LLY
16 May 24
. "With efsitora, we have an opportunity to provide an innovative once-weekly solution that safely achieves and maintains A1C control, reduces treatment burden
3jbabd3a4mj366p0od5466uc8 e64lw0qkd
ABBV
ATNM
AZN
8 May 24
to enhance their portfolios with innovative cancer therapies. Most recently, Swiss pharmaceutical giant Novartis
l1qqjw64g480tmlpttw ys
LLY
6 May 24
toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical
navrbglczhh 7ci
CTLT
LLY
NVO
2 May 24
In Healthcare Guided By AI And The Companies Behind The Innovation
The obesity market is a key battleground for Novo Nordisk and Eli
hvssjot9sywyfnb
LLY
30 Apr 24
. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible
cajm0ny09psh77 on9gp2rzfc9p
LLY
22 Apr 24
at the end of 2025."The acquisition of this state-of-the-art facility underscores our unwavering commitment to growth and innovation, and we look
kkx9ok3kw83w1y1hg8slb
ABBV
ATNM
AZN
22 Apr 24
and an optimistic outlook for mergers and acquisitions (M&A), along with the promise of upcoming innovations. The sector seems primed for a new cycle
bqx q4nqlxee0yjzti4wlxyvr1koi4ielg0xc4kie
ABBV
ATNM
AZN
19 Apr 24
, the biotech industry stands out as a beacon of innovation and growth potential. Actinium Pharmaceuticals, Inc
ylzys6l4snaexd3x4mx1ava73yreda4myf7lsiyujfs14wu
ATNM
AZN
BMY
18 Apr 24
biotech sector continues to benefit from favorable financing conditions and a vibrant outlook for mergers and acquisitions, coupled with innovative
9nkg5imq9ctt2jztjhx dw7sdukznqb5rh0y071xr
LLY
17 Apr 24
. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible
8824fdqc1mvvxr9t51ums50lhtxbdpvkcltz81 bzo1s76ka5s9t
LLY
16 Apr 24
for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines
1c28f16sukaxc2fifalt6jgdli3oqphb7rttwyml63ycoqkua
AVBP
GMAB
LLY
8 Apr 24
for $1.8 billion
The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months